Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxaneMarcin Kubeczko, Fara Brasó-Maristany, Sandra Cobo et al.|npj Breast Cancer|2026Cited by 0
Abstract PS5-01-23: Validation of the HER2DX Genomic Test in First-Line Advanced HER2-Positive Breast Cancer: Identifying Long-Term Responders to THPMarcin Kubeczko, F. Braso-Maritany, Esther Sanfeliu et al.|Clinical Cancer Research|2026Cited by 0
Abstract PS5-01-08: Development of the HER2DX Predictor of Brain Metastasis in Advanced HER2-Positive Breast Cancer Treated with First-Line THPRodrigo Sánchez-Bayona, M. Jarzab, Sandra Cobo et al.|Clinical Cancer Research|2026Cited by 0